Pharmaceutical giant Eli Lilly has significantly escalated its restrictions on access to 340B pricing in the contract pharmacy setting, the [...] …
Articles by : Ted Slafsky, Publisher & CEO
Despite its importance, the 340B drug discount program rarely ever goes under the Congressional spotlight. In fact, until the June [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In last month’s column, I wrote about a reprehensible campaign by 340B opponents to tie this vital drug discount program [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After over 30 years of working in Washington, D.C., I have become accustomed to the expression “politics ain’t beanbag.” The [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
In February, the U.S. Senate bipartisan “Group of Six” released an eagerly anticipated discussion draft bill and a bill summary/request [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
After reviewing comments from over 250 stakeholders, meeting with various interest groups and holding regular staff meetings, the U.S. Senate [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
As we approach the 16-month mark since we had pivotal arguments over the 340B contract pharmacy program in two federal [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four hospital associations are asking a federal judge in Louisiana to throw out a suit filed by the drug industry [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
When I thought about launching 340B Report, the first person I reached out to was Tom Mirga. Tom and I [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Veteran 340B observers were surprised to see that Sen. Bill Cassidy (R-La.) has expanded his 340B investigation into community health [...] …